|
EP2532232A1
|
|
Long chain glycolipids useful to avoid perishing or microbial contamination of materials
|
|
EP2468253A1
|
|
Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
|
|
EP2390343A1
|
|
Production of fatty acids by heterologous expression of gene clusters from myxobacteria
|
|
EP2345646A1
|
|
Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
|
|
SG171779A1
|
|
Inhibitors of hif-1 protein accumulation
|
|
EP2130831A1
|
|
CDC25 inhibitors
|
|
EP2025335A1
|
|
Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism
|
|
EP1939166A1
|
|
Plants extracts for use in brain modulation
|
|
DE102006045097A1
|
|
Uses of crypowellins and their derivatives for the treatment of tumor diseases
|
